Clinical Trial Update: Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating total neoadjuvant therapy with or without tislelizumab for locally advanced rectal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: brenner baruch | Conditions: Locally Advanced Rectal Cancer (LARC) | Phase 2 | Status: RECRUITING